Please assess the completion status of the following clinical trial:

Trial Title: Iron in Congestive Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Congestive heart failure~* At least 18 years of age~* Iron deficiency~* Dyspnea class II or III according to New York Heart Association~* Left-ventricular ejection fraction ≤ 45%~Exclusion Criteria:~* Known sensitivity to any of the products to be administered during dosing~* Immediate need of transfusion~* Patients presenting with an active infection~* Thalassaemia~* Other forms of microcytic anemia not caused by iron deficiency~* History of acquired iron overload~* Need for revascularization, ST-segment elevation myocardial infarction or Non-ST-segment elevation myocardial infarction during the past 3 months (at time of randomization)~* Women who are pregnant or of childbearing age and not using medically acceptable effective contraception

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Iron (Type: ACTIVE_COMPARATOR): ferric carboxymaltose
- Placebo (Type: PLACEBO_COMPARATOR): Sodium chloride 0.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).